The global market for Whole Cell Cholera Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Whole Cell Cholera Vaccine is used to prevent Cholera.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Whole Cell Cholera Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Cell Cholera Vaccine.

The Whole Cell Cholera Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Whole Cell Cholera Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Whole Cell Cholera Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Whole Cell Cholera Vaccine Market Report

Report Metric	Details
Report Name	Whole Cell Cholera Vaccine Market
CAGR	5%
Segment by Type	For Adults For Children
Segment by Application	Clinical Research Institutes Hospital Surgical Centers Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	SBL Vaccine, PaxVax, Valneva SE, GlaxoSmithKline, Johnson and Johnson, Merck, Pfizer, Sanofi Pasteur, AstraZeneca(Medimmune, LLC.), Serum Institute of India
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Whole Cell Cholera Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Whole Cell Cholera Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Whole Cell Cholera Vaccine Market report?

Ans: The main players in the Whole Cell Cholera Vaccine Market are SBL Vaccine, PaxVax, Valneva SE, GlaxoSmithKline, Johnson and Johnson, Merck, Pfizer, Sanofi Pasteur, AstraZeneca(Medimmune, LLC.), Serum Institute of India

What are the Application segmentation covered in the Whole Cell Cholera Vaccine Market report?

Ans: The Applications covered in the Whole Cell Cholera Vaccine Market report are Clinical Research Institutes, Hospital, Surgical Centers, Others

What are the Type segmentation covered in the Whole Cell Cholera Vaccine Market report?

Ans: The Types covered in the Whole Cell Cholera Vaccine Market report are For Adults, For Children

1 Whole Cell Cholera Vaccine Market Overview

1.1 Product Definition

1.2 Whole Cell Cholera Vaccine by Type

1.2.1 Global Whole Cell Cholera Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 For Adults

1.2.3 For Children

1.3 Whole Cell Cholera Vaccine by Application

1.3.1 Global Whole Cell Cholera Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Clinical Research Institutes

1.3.3 Hospital

1.3.4 Surgical Centers

1.3.5 Others

1.4 Global Whole Cell Cholera Vaccine Market Size Estimates and Forecasts

1.4.1 Global Whole Cell Cholera Vaccine Revenue 2020-2031

1.4.2 Global Whole Cell Cholera Vaccine Sales 2020-2031

1.4.3 Global Whole Cell Cholera Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Whole Cell Cholera Vaccine Market Competition by Manufacturers

2.1 Global Whole Cell Cholera Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Whole Cell Cholera Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Whole Cell Cholera Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Whole Cell Cholera Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Whole Cell Cholera Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Whole Cell Cholera Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Whole Cell Cholera Vaccine, Date of Enter into This Industry

2.8 Global Whole Cell Cholera Vaccine Market Competitive Situation and Trends

2.8.1 Global Whole Cell Cholera Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Whole Cell Cholera Vaccine Players Market Share by Revenue

2.8.3 Global Whole Cell Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Whole Cell Cholera Vaccine Market Scenario by Region

3.1 Global Whole Cell Cholera Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Whole Cell Cholera Vaccine Sales by Region: 2020-2031

3.2.1 Global Whole Cell Cholera Vaccine Sales by Region: 2020-2025

3.2.2 Global Whole Cell Cholera Vaccine Sales by Region: 2026-2031

3.3 Global Whole Cell Cholera Vaccine Revenue by Region: 2020-2031

3.3.1 Global Whole Cell Cholera Vaccine Revenue by Region: 2020-2025

3.3.2 Global Whole Cell Cholera Vaccine Revenue by Region: 2026-2031

3.4 North America Whole Cell Cholera Vaccine Market Facts & Figures by Country

3.4.1 North America Whole Cell Cholera Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Whole Cell Cholera Vaccine Sales by Country (2020-2031)

3.4.3 North America Whole Cell Cholera Vaccine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Whole Cell Cholera Vaccine Market Facts & Figures by Country

3.5.1 Europe Whole Cell Cholera Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Whole Cell Cholera Vaccine Sales by Country (2020-2031)

3.5.3 Europe Whole Cell Cholera Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Whole Cell Cholera Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Whole Cell Cholera Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Whole Cell Cholera Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Whole Cell Cholera Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Whole Cell Cholera Vaccine Market Facts & Figures by Country

3.7.1 Latin America Whole Cell Cholera Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Whole Cell Cholera Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Whole Cell Cholera Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Whole Cell Cholera Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Whole Cell Cholera Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Whole Cell Cholera Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Whole Cell Cholera Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Whole Cell Cholera Vaccine Sales by Type (2020-2031)

4.1.1 Global Whole Cell Cholera Vaccine Sales by Type (2020-2025)

4.1.2 Global Whole Cell Cholera Vaccine Sales by Type (2026-2031)

4.1.3 Global Whole Cell Cholera Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Whole Cell Cholera Vaccine Revenue by Type (2020-2031)

4.2.1 Global Whole Cell Cholera Vaccine Revenue by Type (2020-2025)

4.2.2 Global Whole Cell Cholera Vaccine Revenue by Type (2026-2031)

4.2.3 Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Whole Cell Cholera Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Whole Cell Cholera Vaccine Sales by Application (2020-2031)

5.1.1 Global Whole Cell Cholera Vaccine Sales by Application (2020-2025)

5.1.2 Global Whole Cell Cholera Vaccine Sales by Application (2026-2031)

5.1.3 Global Whole Cell Cholera Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Whole Cell Cholera Vaccine Revenue by Application (2020-2031)

5.2.1 Global Whole Cell Cholera Vaccine Revenue by Application (2020-2025)

5.2.2 Global Whole Cell Cholera Vaccine Revenue by Application (2026-2031)

5.2.3 Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Whole Cell Cholera Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 SBL Vaccine

6.1.1 SBL Vaccine Company Information

6.1.2 SBL Vaccine Description and Business Overview

6.1.3 SBL Vaccine Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 SBL Vaccine Whole Cell Cholera Vaccine Product Portfolio

6.1.5 SBL Vaccine Recent Developments/Updates

6.2 PaxVax

6.2.1 PaxVax Company Information

6.2.2 PaxVax Description and Business Overview

6.2.3 PaxVax Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 PaxVax Whole Cell Cholera Vaccine Product Portfolio

6.2.5 PaxVax Recent Developments/Updates

6.3 Valneva SE

6.3.1 Valneva SE Company Information

6.3.2 Valneva SE Description and Business Overview

6.3.3 Valneva SE Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Valneva SE Whole Cell Cholera Vaccine Product Portfolio

6.3.5 Valneva SE Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Company Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 GlaxoSmithKline Whole Cell Cholera Vaccine Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 Johnson and Johnson

6.5.1 Johnson and Johnson Company Information

6.5.2 Johnson and Johnson Description and Business Overview

6.5.3 Johnson and Johnson Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Johnson and Johnson Whole Cell Cholera Vaccine Product Portfolio

6.5.5 Johnson and Johnson Recent Developments/Updates

6.6 Merck

6.6.1 Merck Company Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Merck Whole Cell Cholera Vaccine Product Portfolio

6.6.5 Merck Recent Developments/Updates

6.7 Pfizer

6.7.1 Pfizer Company Information

6.7.2 Pfizer Description and Business Overview

6.7.3 Pfizer Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Pfizer Whole Cell Cholera Vaccine Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Sanofi Pasteur

6.8.1 Sanofi Pasteur Company Information

6.8.2 Sanofi Pasteur Description and Business Overview

6.8.3 Sanofi Pasteur Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sanofi Pasteur Whole Cell Cholera Vaccine Product Portfolio

6.8.5 Sanofi Pasteur Recent Developments/Updates

6.9 AstraZeneca(Medimmune, LLC.)

6.9.1 AstraZeneca(Medimmune, LLC.) Company Information

6.9.2 AstraZeneca(Medimmune, LLC.) Description and Business Overview

6.9.3 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product Portfolio

6.9.5 AstraZeneca(Medimmune, LLC.) Recent Developments/Updates

6.10 Serum Institute of India

6.10.1 Serum Institute of India Company Information

6.10.2 Serum Institute of India Description and Business Overview

6.10.3 Serum Institute of India Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Serum Institute of India Whole Cell Cholera Vaccine Product Portfolio

6.10.5 Serum Institute of India Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Whole Cell Cholera Vaccine Industry Chain Analysis

7.2 Whole Cell Cholera Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Whole Cell Cholera Vaccine Production Mode & Process Analysis

7.4 Whole Cell Cholera Vaccine Sales and Marketing

7.4.1 Whole Cell Cholera Vaccine Sales Channels

7.4.2 Whole Cell Cholera Vaccine Distributors

7.5 Whole Cell Cholera Vaccine Customer Analysis

8 Whole Cell Cholera Vaccine Market Dynamics

8.1 Whole Cell Cholera Vaccine Industry Trends

8.2 Whole Cell Cholera Vaccine Market Drivers

8.3 Whole Cell Cholera Vaccine Market Challenges

8.4 Whole Cell Cholera Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

AstraZeneca(Medimmune, LLC.)

Serum Institute of India

List of Tables

Table 1. Global Whole Cell Cholera Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Whole Cell Cholera Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Whole Cell Cholera Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Whole Cell Cholera Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Whole Cell Cholera Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Whole Cell Cholera Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Whole Cell Cholera Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Whole Cell Cholera Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Whole Cell Cholera Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Whole Cell Cholera Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Whole Cell Cholera Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Whole Cell Cholera Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Cell Cholera Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Whole Cell Cholera Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Whole Cell Cholera Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global Whole Cell Cholera Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Whole Cell Cholera Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global Whole Cell Cholera Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Whole Cell Cholera Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Whole Cell Cholera Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Whole Cell Cholera Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Whole Cell Cholera Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Whole Cell Cholera Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Whole Cell Cholera Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America Whole Cell Cholera Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America Whole Cell Cholera Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Whole Cell Cholera Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Whole Cell Cholera Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Whole Cell Cholera Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Whole Cell Cholera Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Whole Cell Cholera Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Whole Cell Cholera Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Whole Cell Cholera Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Whole Cell Cholera Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Whole Cell Cholera Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Whole Cell Cholera Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Whole Cell Cholera Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Whole Cell Cholera Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Whole Cell Cholera Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Whole Cell Cholera Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Whole Cell Cholera Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Whole Cell Cholera Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Whole Cell Cholera Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Whole Cell Cholera Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Whole Cell Cholera Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Whole Cell Cholera Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Whole Cell Cholera Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Whole Cell Cholera Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global Whole Cell Cholera Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Type (2020-2025)

Table 59. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Type (2026-2031)

Table 60. Global Whole Cell Cholera Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global Whole Cell Cholera Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Application (2020-2025)

Table 69. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Application (2026-2031)

Table 70. SBL Vaccine Company Information

Table 71. SBL Vaccine Description and Business Overview

Table 72. SBL Vaccine Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. SBL Vaccine Whole Cell Cholera Vaccine Product

Table 74. SBL Vaccine Recent Developments/Updates

Table 75. PaxVax Company Information

Table 76. PaxVax Description and Business Overview

Table 77. PaxVax Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. PaxVax Whole Cell Cholera Vaccine Product

Table 79. PaxVax Recent Developments/Updates

Table 80. Valneva SE Company Information

Table 81. Valneva SE Description and Business Overview

Table 82. Valneva SE Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Valneva SE Whole Cell Cholera Vaccine Product

Table 84. Valneva SE Recent Developments/Updates

Table 85. GlaxoSmithKline Company Information

Table 86. GlaxoSmithKline Description and Business Overview

Table 87. GlaxoSmithKline Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. GlaxoSmithKline Whole Cell Cholera Vaccine Product

Table 89. GlaxoSmithKline Recent Developments/Updates

Table 90. Johnson and Johnson Company Information

Table 91. Johnson and Johnson Description and Business Overview

Table 92. Johnson and Johnson Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Johnson and Johnson Whole Cell Cholera Vaccine Product

Table 94. Johnson and Johnson Recent Developments/Updates

Table 95. Merck Company Information

Table 96. Merck Description and Business Overview

Table 97. Merck Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Merck Whole Cell Cholera Vaccine Product

Table 99. Merck Recent Developments/Updates

Table 100. Pfizer Company Information

Table 101. Pfizer Description and Business Overview

Table 102. Pfizer Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Pfizer Whole Cell Cholera Vaccine Product

Table 104. Pfizer Recent Developments/Updates

Table 105. Sanofi Pasteur Company Information

Table 106. Sanofi Pasteur Description and Business Overview

Table 107. Sanofi Pasteur Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Sanofi Pasteur Whole Cell Cholera Vaccine Product

Table 109. Sanofi Pasteur Recent Developments/Updates

Table 110. AstraZeneca(Medimmune, LLC.) Company Information

Table 111. AstraZeneca(Medimmune, LLC.) Description and Business Overview

Table 112. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product

Table 114. AstraZeneca(Medimmune, LLC.) Recent Developments/Updates

Table 115. Serum Institute of India Company Information

Table 116. Serum Institute of India Description and Business Overview

Table 117. Serum Institute of India Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Serum Institute of India Whole Cell Cholera Vaccine Product

Table 119. Serum Institute of India Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Whole Cell Cholera Vaccine Distributors List

Table 123. Whole Cell Cholera Vaccine Customers List

Table 124. Whole Cell Cholera Vaccine Market Trends

Table 125. Whole Cell Cholera Vaccine Market Drivers

Table 126. Whole Cell Cholera Vaccine Market Challenges

Table 127. Whole Cell Cholera Vaccine Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Whole Cell Cholera Vaccine

Figure 2. Global Whole Cell Cholera Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Whole Cell Cholera Vaccine Market Share by Type: 2024 & 2031

Figure 4. For Adults Product Picture

Figure 5. For Children Product Picture

Figure 6. Global Whole Cell Cholera Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Whole Cell Cholera Vaccine Market Share by Application: 2024 & 2031

Figure 8. Clinical Research Institutes

Figure 9. Hospital

Figure 10. Surgical Centers

Figure 11. Others

Figure 12. Global Whole Cell Cholera Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Whole Cell Cholera Vaccine Market Size (2020-2031) & (US$ Million)

Figure 14. Global Whole Cell Cholera Vaccine Sales (2020-2031) & (K Units)

Figure 15. Global Whole Cell Cholera Vaccine Average Price (USD/Unit) & (2020-2031)

Figure 16. Whole Cell Cholera Vaccine Report Years Considered

Figure 17. Whole Cell Cholera Vaccine Sales Share by Manufacturers in 2024

Figure 18. Global Whole Cell Cholera Vaccine Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Whole Cell Cholera Vaccine Players: Market Share by Revenue in Whole Cell Cholera Vaccine in 2024

Figure 20. Whole Cell Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Whole Cell Cholera Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Whole Cell Cholera Vaccine Sales Market Share by Country (2020-2031)

Figure 23. North America Whole Cell Cholera Vaccine Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Whole Cell Cholera Vaccine Sales Market Share by Country (2020-2031)

Figure 27. Europe Whole Cell Cholera Vaccine Revenue Market Share by Country (2020-2031)

Figure 28. Germany Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Whole Cell Cholera Vaccine Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Whole Cell Cholera Vaccine Revenue Market Share by Region (2020-2031)

Figure 35. China Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Whole Cell Cholera Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Latin America Whole Cell Cholera Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Whole Cell Cholera Vaccine Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Whole Cell Cholera Vaccine Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Whole Cell Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Whole Cell Cholera Vaccine by Type (2020-2031)

Figure 56. Global Revenue Market Share of Whole Cell Cholera Vaccine by Type (2020-2031)

Figure 57. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Whole Cell Cholera Vaccine by Application (2020-2031)

Figure 59. Global Revenue Market Share of Whole Cell Cholera Vaccine by Application (2020-2031)

Figure 60. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Application (2020-2031)

Figure 61. Whole Cell Cholera Vaccine Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions